Company: THC
Filing Date: 2025-04-11
Form Type: DEF 14A
Source: 0001193125-25-079143
Chunk: 19

Company: TENET HEALTHCARE CORP
Filing Date: 2025-04-11
Form: DEF 14A
Chunk 19
---
 and processes applicable to the evaluation of candidates proposed by other sources.

| * | Information included on our website and in any reports on our website shall not be deemed a part of, and is not incorporated by reference into, this Proxy Statement. |

| CANDIDATE RECOMMENDATIONS      |     | GOVERNANCE   COMMITTEE                                                                   |     | BOARD OF DIRECTORS        |     | SHAREHOLDERS        |
| From Shareholders, Management, 
 Directors, Professional Search 
 Firms and Other Sources        |     | Discusses and Reviews                                                                    
 Qualifications and Expertise                                                             
 Enterprise Strategy Board Needs Current Board Composition Interviews Recommends Nominees |     | Discusses Governance      
 Committee Recommendations 
 Analyzes Independence     
 Selects Nominees          |     | Vote on Nominees at 
 Annual Meeting      |

Assessment of Board Composition and Criteria for Board Membership The Governance Committee evaluates the composition of the Board on an ongoing basis and considers potential nominees to the Board as appropriate. As part of this process, the Governance Committee reviews the composition of the Board as a whole, including the business backgrounds, qualifications, skillsets and other qualities represented on the Board to provide the right balance to effectively oversee management. The Governance Committee assesses its effectiveness in this regard as part of the annual Board evaluation process. The Governance Committee also reviews updated biographical information for each incumbent director on an annual basis, including information relating to changes in professional status, independence, other professional commitments and other public company directorships. In light of our current structure and operations, and in consideration of the

| 2025 PROXY STATEMENT |     | 21 |

Proposal 1 -Election of Directors evaluation of the Board’s composition, the Governance Committee believes the following criteria should be represented on the Company’s Board:

| Professionalism, dedication, business judgment, integrity and commitment to the Company’s mission |     | Expertise in financial and accounting matters and familiarity with the regulatory and corporate governance requirements applicable to public companies |     | Service as the chief executive officer or in other senior leadership positions in a company or major governmental, professional or non-profit organization |

| Experience in the healthcare industry or other relevant industry experience |     | Variety of personal and occupational backgrounds, including ethnicity, gender, experience and viewpoints |     | Government, regulatory and public sector experience |

| Ability and willingness to commit adequate time to Board and committee matters |     | Degree to which the individual’s skills complement those of other directors and potential nominees |     | Familiarity